Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Towa Pharmaceutical Co. Ltd.

www.towayakuhin.co.jp/english/

Latest From Towa Pharmaceutical Co. Ltd.

Deal Watch: Pfizer Licenses Skin-Targeted JAK Inhibitor Portfolio From Theravance

Deal with Pfizer makes for Theravance’s third large pharma partnership since 2016. AbbVie off-loads Marinol to India’s Alkem, Bausch licenses candidate for rare form of dry eye disease from Novaliq.

Deals M & A

Towa Expands Internationally With Esteve’s Pensa

Japan’s Towa has struck a deal to acquire the Pensa Investments generics division of Spain’s Esteve in an all-cash transaction worth €320m. The acquisition gives Towa access to the Spanish market as well as subsidiaries in Europe and the US.

Deals Strategy

Towa Lines Up More Launches

Towa has announced plans to launch two new products in December 2019, after the Japanese company reported an increase in sales in its financial first half due to recently-launched products.

Sales & Earnings Strategy

Japan’s Towa Plans Four New Launches In June

Towa says it has lined up four new drugs for launch in June as it has reported annual results that beat company forecasts.  

Strategy Sales & Earnings
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
    • Generic Drugs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • Towa Pharmaceutical Co. Ltd.
  • Senior Management
  • Itsuro Yoshida, Pres. & CEO
    Shinya Kida, Gen. Mgr., Fin. & Accounting
  • Contact Info
  • Towa Pharmaceutical Co. Ltd.
    Phone: (81) 6 69009103
    2-11 Shinbashi-Cho
    Kadoma
    Osaka, 571-8580
    Japan
UsernamePublicRestriction

Register